
Top Stories 
Published On May 3, 2010
CLINICAL RESEARCH
Defined: Zinc Fingers
With zinc finger technology, scientists might be able to “cut and paste” DNA to fight certain diseases.
zinc fingers: proteins found naturally in plant and animal cells that might yield an improved form of gene therapy and are the focus of current attempts to treat HIV/AIDS by mimicking a mutation that makes people resistant to the virus.
Zinc fingers—so-called because each molecular “finger” has a stabilizing zinc atom at its center and because researchers, first seeing them in 2-D, thought they looked like fingers (in fact, they’re U-shaped)—naturally regulate the activity of genes by binding to DNA. Cambridge University chemist Aaron Klug, who discovered the proteins in 1985, and others have spent the past 25 years trying to create customized zinc fingers that can edit human DNA by knocking out or adding gene sequences, adding beneficial mutations or correcting disease-causing ones.
The University of Pennsylvania and Sangamo BioSciences are using customized zinc fingers—known as zinc finger nucleases (ZFNs)—in attempts to simulate one particular, beneficial mutation: the disruption of a gene called CCR5 from human DNA. Because CCR5 is essential for common types of HIV to enter immune cells, people born without a functional CCR5 gene are resistant to HIV infection. Researchers are using ZFNs to disrupt the gene from HIV patients’ DNA in hopes that once a CD4 T-cell (the most important white blood cell for fighting HIV/AIDS) does not make functional CCR5, HIV/AIDS will be unable to kill that cell, decreasing the patient’s viral load and improving his or her immune system.
Dispatches

What Makes a Kid Clumsy? More research into coordination disorders shows why some children are more prone to trip, fumble and spill the milk.

Eyes in the Sky Satellite data can be used to assess the health impact of dust storms and the spread of mosquito-borne diseases. Additional applications could be on the horizon.

Could This One Change Help Curb the Opioid Crisis? To prescribe an effective bridge to addiction treatment, emergency physicians must get special training and receive a waiver. Making that process easier—or eliminating the requirement altogether—could make a big impact.

One Thing Leads to the Next Robert Lefkowitz is best known for revealing the mechanism behind hundreds of drugs in use today. But he thinks of himself as a storyteller first and has a new book out to make his case.

Podcast: The Research Year That Was Medical research labs have faced a difficult stretch of closed buildings and competing priorities. Yet they have also produced milestone discoveries—and not only on COVID-19.

The Shape of Us Two milestone discoveries in protein modeling promise to change the fundamentals of drug discovery.

Universal Flu Vaccines Move Forward In the shadow of coronavirus vaccine development, another vaccine was making solid progress.

Top Stories 

The Neuroscience of Giving Up
Why do some people react poorly, even catastrophically, in emergency situations?